Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 3662 (108th)

State and Local Access to Fair Prescription Drug Prices Act

referredUnited States· United States Congress· EN

Introduced

8 December 2003

Last action

17 December 2003 · Referred

Status

Referred to the Subcommittee on Health.

Sponsors

Rep. Allen, Thomas H. [D-ME-1], Rep. Waxman, Henry A. [D-CA-33], Rep. Stark, Fortney Pete [D-CA-13], Sen. Brown, Sherrod [D-OH], Rep. Pallone, Frank [D-NJ-6], Sen. Markey, Edward J. [D-MA], Rep. Meehan, Martin T. [D-MA-5], Rep. Berry, Marion [D-AR-1], Rep. Michaud, Michael H. [D-ME-2], Rep. Schakowsky, Janice D. [D-IL-9], Rep. Frank, Barney [D-MA-4], Rep. Olver, John W. [D-MA-1], Rep. Case, Ed [D-HI-1], Rep. Emerson, Jo Ann [R-MO-8], Rep. Stupak, Bart [D-MI-1], Rep. Oberstar, James L. [D-MN-8], Rep. McGovern, James P. [D-MA-2], Del. Norton, Eleanor Holmes [D-DC-At Large], Rep. Filner, Bob [D-CA-51]

Subjects

Healthcare

Source updated

18 August 2025

Healthcare

Summary

State and Local Access to Fair Prescription Drug Prices Act - Requires a participating manufacturer of a covered outpatient drug to make available for purchase by each State for the benefit of its residents whose cost of covered outpatient drugs is paid for by the State through a group health program, a retiree health program, a State or local pharmaceutical assistance program, or other similar program (including a State Medicaid program), such covered outpatient drug in an amount equal to the aggregate amount of a covered drug sold in a State at a price that is no greater than the manufacturer's average foreign price. (Makes such provision applicable to local governments under similar outpatient drug purchase arrangements.) Applies such requirement to direct purchases by State or local organizations or agents. Sets forth enforcement provisions, including manufacturer debarment for repeat violations. Permits a State, with respect to its provision of Medicaid assistance for covered outpatient drugs, to: (1) continue its Medicaid rebate agreement; or (2) disregard the manufacturer's average foreign price in determining the best price under a rebate agreement. Defines specified terms.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 8 December 2003

    Introduced

    Referred to the House Committee on Energy and Commerce.

    Source: IntroReferral

  2. 8 December 2003

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 8 December 2003

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 17 December 2003

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 8 December 2003

    ViewDownloadOpen at official source

  • Introduced in House (PDF)

    Introduced in House · EN · 8 December 2003

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 8 December 2003

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.